GLPG vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ARAV, ACABW, BFRIW, BTMDW, and BCTXW
Should you be buying Galapagos stock or one of its competitors? The main competitors of Galapagos include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), ARAVIVE (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.
Galapagos vs. Its Competitors
Galapagos (NASDAQ:GLPG) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, media sentiment, dividends and profitability.
Galapagos currently has a consensus target price of $25.33, suggesting a potential downside of 12.14%. Given Galapagos' stronger consensus rating and higher probable upside, equities research analysts plainly believe Galapagos is more favorable than 180 Life Sciences.
In the previous week, Galapagos had 2 more articles in the media than 180 Life Sciences. MarketBeat recorded 2 mentions for Galapagos and 0 mentions for 180 Life Sciences. Galapagos' average media sentiment score of 0.29 beat 180 Life Sciences' score of 0.00 indicating that Galapagos is being referred to more favorably in the media.
Galapagos has higher revenue and earnings than 180 Life Sciences.
32.5% of Galapagos shares are owned by institutional investors. 2.9% of Galapagos shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Summary
Galapagos beats 180 Life Sciences on 7 of the 7 factors compared between the two stocks.
Get Galapagos News Delivered to You Automatically
Sign up to receive the latest news and ratings for GLPG and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding GLPG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Galapagos Competitors List
Related Companies and Tools
This page (NASDAQ:GLPG) was last updated on 7/4/2025 by MarketBeat.com Staff
Free GLPG Stock Alerts